And youre definitely not alone
Unqualified backing by the new administration Things are looking bleak on this front, given Kennedys antipathy, though perhaps the more progressive views on GLP-1s of Mehmet Oz, the recently confirmed CMS administrator, will help
Clinicians emphasize shared decision-making: consider efficacy gaps, side-effect profiles, and patient goals
Rubino DM, Greenway FL, Khalid U, ONeil PM, Rosenstock J, Srrig R, Wadden TA, Wizert A, Garvey WT, Arauz-Pacheco C
Food and Drug Administration (FDA) for managing type 2 diabetes under the brand names Ozempic (injection) and Rybelsus (tablet), and for chronic weight management as Wegovy , this medication continues to make a major impact in both clinical and wellness settings
West Virginia has the highest usage rate at 24%, followed by Kentucky (22%), Louisiana (20%) and Oklahoma